Status:
UNKNOWN
Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)
Lead Sponsor:
University of Cincinnati
Collaborating Sponsors:
The Cleveland Clinic
Conditions:
Sarcoidosis
Pulmonary Hypertension
Eligibility:
All Genders
18-100 years
Brief Summary
Registry to follow patients with sarcoidosis associated pulmonary hypertension
Detailed Description
This is a multi center registry of sarcoidosis associated pulmonary hypertension (SAPH). With this registry, the investigators will characterize the demographics, clinical course, hemodynamics, pulmon...
Eligibility Criteria
Inclusion
- Patients with sarcoidosis as defined by the ATS/WASOG statement
- Patients with pulmonary hypertension as confirmed by right heart catheterization
- Patients willing to provide written informed consent
Exclusion
- Unwillingness to provide assurance that they will complete the follow up visits for the study
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2018
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01467791
Start Date
November 1 2011
End Date
January 1 2018
Last Update
December 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cincinnati
Cincinnati, Ohio, United States, 45267